These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7752076)

  • 21. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
    Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
    Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
    Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR
    Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y; Gafni M; Keren O; Sarne Y
    Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells.
    Standifer KM; Cheng J; Brooks AI; Honrado CP; Su W; Visconti LM; Biedler JL; Pasternak GW
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1246-55. PubMed ID: 7932177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
    Hatzoglou A; Bakogeorgou E; Castanas E
    Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of norepinephrine release from rat cortex slices by opioids: differences among agonists in sensitivities to antagonists suggest receptor heterogeneity.
    Kim KW; Cox BM
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1153-60. PubMed ID: 8263776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
    Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
    J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
    Poonyachoti S; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
    Xu H; Lu YF; Rothman RB
    Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
    Zernig G; Burke T; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
    Chen Y; Mestek A; Liu J; Hurley JA; Yu L
    Mol Pharmacol; 1993 Jul; 44(1):8-12. PubMed ID: 8393525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ambient temperature on the ability of mu-, kappa- and delta-selective opioid agonists to modulate thermoregulatory mechanisms in the rat.
    Handler CM; Piliero TC; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):847-55. PubMed ID: 8113997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells.
    Yu VC; Sadée W
    J Pharmacol Exp Ther; 1988 Apr; 245(1):350-5. PubMed ID: 2834542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyr-c[D-Orn-Tyr(Bzl)-Pro-Gly]: a novel antiproliferative acting somatostatin receptor agonist with mu-opioid receptor-sensitizing properties.
    Stirnweiss J; Hartrodt B; Greksch G; Stürzebecher U; Böhmer FD; Neubert K; Liebmann C
    Br J Pharmacol; 2003 Sep; 140(1):13-22. PubMed ID: 12967930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cells.
    Belcheva MM; Gucker S; Chuang DM; Clark WG; Jefcoat LB; McHale RJ; Toth G; Borsodi A; Coscia CJ
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1513-23. PubMed ID: 7562528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line.
    Cheng J; Standifer KM; Tublin PR; Su W; Pasternak GW
    J Neurochem; 1995 Jul; 65(1):170-5. PubMed ID: 7790858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.